Eckenstein-Geigy-Stiftung

Eckenstein-Geigy-Stiftung is a Swiss investment firm owned by the Eckenstein family. It invests money in companies such as technological startups across Switzerland. Eckenstein-Geigy-Stiftung has a headquarters in Basel in Switzerland.

Gabriel Eckenstein

Foundation Director

7 past transactions

Leon Nanodrugs

Series D in 2024
Leon Nanodrugs is a specialized product development company focused on enhancing existing drug formulations through advanced nanotechnology. The company develops a pipeline of improved drug products aimed at increasing the bioavailability of poorly water-soluble medicines. Utilizing its proprietary MJR® Technology platform, Leon Nanodrugs creates both polymeric and crystalline nanoparticles, which provide significant differentiation and added benefits for patients. The company also offers services that support pre-clinical and clinical-stage formulations for clients’ new chemical entities or established branded drugs, facilitating access to next-generation nano-formulated therapies that aim to improve patient outcomes.

Ampersand

Venture Round in 2024
Ampersand is a company based in Kigali, Rwanda, that specializes in the manufacture of affordable electric vehicles and charging systems tailored for the three million motorcycle taxi drivers in East Africa. The company aims to enhance mass-market electric mobility by providing a battery swap network and an operating system that facilitates sustainable transport solutions. By making electric mobility accessible and affordable, Ampersand not only improves the livelihoods of drivers but also contributes to environmental sustainability. As of January 2024, the company's customer base has expanded to 2,000 users, who collectively cover 1.5 million kilometers weekly in Nairobi and Kigali.

b-rayZ

Series A in 2022
b-rayZ is a spin-off from University Hospital Zurich that develops artificial intelligence tools for medical imaging. Its team blends radiologists, data scientists and physicians with extensive experience in imaging and radiology. The company creates predictive deep learning analytics to assess personal medical images and to support radiologists in mammography by providing real-time image quality and breast density assessments. The software enables standardized evaluation of imaging data to improve breast cancer detectability and aims to enhance diagnostic accuracy and efficiency, potentially reducing healthcare costs.

NeoPrediX

Venture Round in 2021
NeoPrediX develops decision support tools and digital health solutions for maternal, neonatal, and perinatal screening to evaluate, optimize, and personalize medical strategies in pediatrics. It translates medical data into intelligent predictions using advanced algorithms to support clinical decisions in neonatal and perinatal care, enabling practitioners to tailor treatments in early life and reduce the risk of long-term complications.

Leon Nanodrugs

Series B in 2020
Leon Nanodrugs is a specialized product development company focused on enhancing existing drug formulations through advanced nanotechnology. The company develops a pipeline of improved drug products aimed at increasing the bioavailability of poorly water-soluble medicines. Utilizing its proprietary MJR® Technology platform, Leon Nanodrugs creates both polymeric and crystalline nanoparticles, which provide significant differentiation and added benefits for patients. The company also offers services that support pre-clinical and clinical-stage formulations for clients’ new chemical entities or established branded drugs, facilitating access to next-generation nano-formulated therapies that aim to improve patient outcomes.

VieBeg

Pre Seed Round in 2019
VieBeg operates a data-driven logistics platform focused on the procurement of medical and dental supplies and equipment. By leveraging AI technology, the company enhances inventory management and utilizes real-time data and pattern recognition to streamline the procurement process. This enables healthcare facilities to efficiently manage their stock levels, ensuring they have the appropriate types and quantities of medical supplies readily available for patient care. VieBeg's approach aims to improve accessibility to affordable medical equipment, ultimately supporting healthcare providers in preventing health crises and delivering effective treatment.

Urban Farmers

Series A in 2015
UrbanFarmers specializes in creating urban agriculture systems that integrate aquaponics, allowing for the cultivation of fish and plants in urban environments. The company focuses on developing rooftop farm solutions tailored for commercial growers and food retailers, utilizing unused spaces such as empty buildings and rooftops. By transforming these underutilized areas into productive agricultural sites, UrbanFarmers enables clients to maximize their real estate while contributing to sustainable food production in urban settings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.